Results 231 to 240 of about 314,969 (284)

Chinese medical named entity recognition utilizing entity association and gate context awareness. [PDF]

PLoS One
Yan Y, Kang Y, Huang W, Cai X.
europepmc   +1 more source

Post‐LECA Origin and Diversification of an Axonemal Outer Arm Dynein Motor

Cytoskeleton, EarlyView.
ABSTRACT Dyneins were present in the last eukaryotic common ancestor (LECA) and play key roles in eukaryotic biology. Axonemal dyneins form the inner and outer arms that power ciliary beating, and it has long been recognized that outer arms in some organisms contain two different heavy chain motors, whereas those from other species contain a third unit
Stephen M. King
wiley   +1 more source

Generative named entity recognition framework for Chinese legal domain. [PDF]

PeerJ Comput Sci
Mao X, Jiang J, Zeng Y, Peng Y, Zhang S, Li F.   +5 more
europepmc   +1 more source

Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects

Cancer Nexus, EarlyView.
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han, Ying Wang, Xintao Gao, Yan Lei, Yantao Li, Zhiyong Tang   +5 more
wiley   +1 more source

A Position- and Similarity-Aware Named Entity Recognition Model for Power Equipment Maintenance Work Orders. [PDF]

Sensors (Basel)
Wei Z, Qu S, Zhao L, Shi Q, Zhang C.
europepmc   +1 more source

A Comparison of Regional Decisions for Doses and Administrations of New Drugs: Concordance, Discordance, and Dependencies

Clinical Pharmacology &Therapeutics, EarlyView.
Regional differences in approved drug dosages and administration are shaped by complex factors, including clinical data, prior regulatory decisions, and region‐specific considerations. This study investigated how such factors are associated with variations in approved doses across the United States Food and Drug Administration (FDA), European Medicines
Sachiko Mita, Shunsuke Ono
wiley   +1 more source

A text-speech multimodal Chinese named entity recognition model for crop diseases and pests. [PDF]

Sci Rep
Liu R, Guo X, Zhu H, Wang L.
europepmc   +1 more source

MAHE: a multiscale and hybrid expert-based model for image-text enhanced named entity recognition on social media. [PDF]

Sci Rep
Yang S, Mo B, Liu D, Zhu L.
europepmc   +1 more source

Named entity recognition of pharmacokinetic parameters in the scientific literature. [PDF]

Sci Rep
Gonzalez Hernandez F, Nguyen Q, Smith VC, Cordero JA, Ballester MR, Duran M, Solé A, Chotsiri P, Wattanakul T, Mundin G, Lilaonitkul W, Standing JF, Kloprogge F.   +12 more
europepmc   +1 more source